CymaBay Therapeutics
Why Robinhood?
You can watch CBAY and buy or sell other stocks, ETFs, and their options commission-free!About CBAY
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001.
CBAY Key Statistics
Stock Snapshot
With a market cap of 3.73B, CymaBay Therapeutics(CBAY) trades at $32.48. The stock has a price-to-earnings ratio of -32.75.
On 2026-03-12, CymaBay Therapeutics(CBAY) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for CymaBay Therapeutics(CBAY) stock has reached 0, versus its average volume of 1.85M.
The stock's 52-week range extends from a low of $7.26 to a high of $32.50.
The stock's 52-week range extends from a low of $7.26 to a high of $32.50.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.